Filing Details
- Accession Number:
- 0001179110-15-007281
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-05-07 17:52:10
- Reporting Period:
- 2015-05-05
- Filing Date:
- 2015-05-07
- Accepted Time:
- 2015-05-07 17:52:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
815094 | Abiomed Inc | ABMD | Surgical & Medical Instruments & Apparatus (3841) | 042743260 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1372715 | J Andrew Greenfield | C/O Abiomed, Inc. 22 Cherry Hill Drive Danvers MA 01923 | Vp Healthcare Solutions | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $.01 Par Value | Acquisiton | 2015-05-05 | 10,500 | $0.00 | 72,238 | No | 4 | A | Direct | |
Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 1,877 | $70.22 | 70,361 | No | 4 | S | Direct | |
Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 700 | $71.21 | 69,661 | No | 4 | S | Direct | |
Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 623 | $72.10 | 69,038 | No | 4 | S | Direct | |
Common Stock, $.01 Par Value | Disposition | 2015-05-07 | 300 | $73.13 | 68,738 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $13.57 | 2007-06-01 | 2016-06-01 | 0 | 40,000 | Direct |
Common Stock | Stock Option (right to buy) | $11.27 | 2008-05-30 | 2017-05-30 | 0 | 10,000 | Direct |
Common Stock | Stock Option (right to buy) | $13.80 | 2009-05-23 | 2018-05-23 | 0 | 9,000 | Direct |
Common Stock | Stock Option (right to buy) | $10.03 | 2011-06-03 | 2020-06-03 | 0 | 25,000 | Direct |
Common Stock | Stock Option (right to buy) | $22.44 | 2013-05-22 | 2022-05-22 | 0 | 20,000 | Direct |
Common Stock | Stock Option (right to buy) | $14.39 | 2014-02-19 | 2023-02-19 | 0 | 20,000 | Direct |
Common Stock | Stock Option (Right to Buy) | $23.15 | 2014-05-14 | 2023-05-14 | 0 | 20,000 | Direct |
Common Stock | Stock Option (right to buy) | $21.55 | 2015-05-14 | 2024-05-14 | 0 | 15,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2016-06-01 | 0 | 40,000 | Direct |
2017-05-30 | 0 | 10,000 | Direct |
2018-05-23 | 0 | 9,000 | Direct |
2020-06-03 | 0 | 25,000 | Direct |
2022-05-22 | 0 | 20,000 | Direct |
2023-02-19 | 0 | 20,000 | Direct |
2023-05-14 | 0 | 20,000 | Direct |
2024-05-14 | 0 | 15,000 | Direct |
Footnotes
- Grant to reporting person of option to buy shares of Common Stock under ABIOMED, Inc. 2000 Stock Incentive Plan.
- These options became exercisable in annual 25% increments, commencing on the date shown in Table II, Column 6.
- Grant to reporting person of option to buy shares of Common Stock under ABIOMED, Inc. 2008 Stock Incentive Plan.
- These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on May 14, 2014. One third of these restricted stock units vested on May 5, 2015 (into an equal number of shares of common stock) upon the issuer's achievement of a certain performance milestone with the remaining vesting on the first and second anniversary of the date of the grant.
- Sale of common stock pursuant to reporting owner's 10b5-1 plan, including for payment of withholding tax liability associated with the vesting of performance-based awards of restricted stock units.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.7900 and $70.7500. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.8000 and $71.7200. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.9000 and $72.7100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
- This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.9300 and $73.3100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.